The following webinar took place back on August 31st, 2021 in honor of Autoinflammatory Awareness Month and Still’s Disease Awareness Day (Sept 7). Nonprofit supporters included International Foundation for Autoimmune & Autoinflammatory Arthritis (AiArthritis), Systemic JIA Foundation, and the Autoinflammatory Alliance. Financial support was provided by Sobi and Avalo Therapeutics.
Current study opportunities
- Sobi (MAS): Evaluate Efficacy, Safety and Tolerability, PK and PD, of Emapalumab in Children and Adults With MAS in Still’s or SLE (link)
- Avalo Therapeutics (IL-18): A Study to Evaluate AEVI-007 in Participants With Adult-Onset Still’s Disease (link)
AiArthritis also shared two PDFs in a recent email –
Learn more about AiArthritis’ Still’s Disease work.